Community-acquired bacterial meningitis in elderly patients: experience over 30 years
- PMID: 19282702
- DOI: 10.1097/MD.0b013e31819d50ef
Community-acquired bacterial meningitis in elderly patients: experience over 30 years
Abstract
Clinical characteristics, etiologies, evolution, and prognostic factors of community-acquired bacterial meningitis in elderly patients are not well known. To improve this knowledge, all episodes of community-acquired bacterial meningitis were prospectively recorded and cases occurring in patients >or=65 years old were selected. During the period 1977-2006, 675 episodes in adults (aged >or=18 yr) were recorded, with 185 (27%) in patients aged >or=65 years old; 76 were male and 109 were female, with a mean age of 73 +/- 6 years (range, 65-93 yr). Causative microorganisms were Streptococcus pneumoniae 74, Neisseria meningitidis 49, Listeria monocytogenes 17, other streptococcal 9, Escherichia coli 6, Haemophilus influenzae 4, Klebsiella pneumoniae and Staphylococcus aureus 2 each, Capnocytophaga canimorsus and Enterococcus faecalis 1 each, and unknown in 20. On admission 91% had had fever, 32% were in a coma (Glasgow Coma Scale <or=8), 9% presented with seizures, and 8% with shock. Thirty patients (16%) presented with seizures during therapy. Mortality was 58/185 (31%). Compared with patients aged 18-65 years, there were significant differences among older patients (aged >or=65 yr), who showed a higher frequency of diabetes and malignancy as underlying disease; pneumonia, otitis, and pericranial fistula as predisposing factors; and S. pneumoniae and L. monocytogenes as etiology. There were also differences in clinical presentation, complications, sequelae, and mortality. Factors independently related with mortality were age, pneumonia as a predisposing factor, coma on admission, and heart failure and seizures after therapy. Dexamethasone therapy was a protective factor. In conclusion, bacterial meningitis in elderly patients is associated with greater diagnostic difficulties and neurologic severity and more complications, as well as with increased mortality. Antiseizure prophylaxis might be useful in these patients.
References
-
- Behrman RE, Meyers BR, Mendelson MH, Sacks HS, Hirschman SZ. Central nervous system infections in the elderly. Arch Intern Med. 1989;149:1596-1599.
-
- Cabellos C, Viladrich PF, Verdaguer R, Pallarés R, Linares J, Gudiol F. A single daily dose of ceftriaxone for bacterial meningitis in adults. Experience with 84 cases and review of the literature. Clin Infect Dis. 1995;20:1164-1168.
-
- Choi C. Bacterial meningitis in aging adults. Clin Infect Dis. 2001;33:1380-1385.
-
- Dauchy FA, Gruson D, Chene G, Viot J, Bebear C, Maugein J, Bezian MC, Dutrone H, Dupon M. Prognostic factors in adult community-acquired bacterial meningitis: a 4-year retrospective study. Eur J Clin Microb Infect Dis. 2007;26:743-746.
-
- De Gans J, van de Beek D, for the European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002;347:1549-1556.
MeSH terms
LinkOut - more resources
Full Text Sources
